Summary
Increasing rates of obesity, lack of physical activity, sedentary behavior, and frequent alcohol consumption are major lifestyle-related risk factors for breast cancer. In fact, it has been estimated that about one-third of breast cancer cases are attributable to factors women can change. Most research has focused on examining the impact of one single exposure on breast cancer risk while adjusting for other risk modifiers. Capitalizing on big data, major efforts have been made to evaluate the combined impact of well-established lifestyle factors on overall breast cancer risk. At the individual level, data indicate that even simple behavior modifications could have a considerable impact on breast cancer prevention. Moreover, there is emerging new evidence that adopting a healthy lifestyle may be particularly relevant for women with hereditary susceptibility to breast cancer. On the absolute risk scale, studies suggest that the presence of certain risk factors, such as excessive body weight, had a substantially higher impact on breast cancer risk if women had a hereditary predisposition to cancer. The existing body of knowledge gives the medical professionals guidance as to which factors to focus on when counseling patients. However, well-designed randomized controlled trials utilizing objective methods are crucial to providing concrete recommendations.
References
1.
Islami F, Goding Sauer A, Miller KD, et al: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:31-54.
2.
Ma J, Ward EM, Siegel RL, Jemal A: Temporal trends in mortality in the United States, 1969-2013. JAMA 2015;314:1731-1739.
3.
ASCO: National Cancer Opinion Survey, 2017. www.asco.org/research-progress/reports-studies/national-cancer-opinion-survey.
4.
Massetti GM, Dietz WH, Richardson LC: Excessive weight gain, obesity, and cancer: opportunities for clinical intervention. JAMA 2017;318:1975-1976.
5.
Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol 2018;6:95-104.
6.
Kerr J, Anderson C, Lippman SM: Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol 2017;18:e457-471.
7.
World Cancer Research Fund International/AICR: Continuous Update Project Report: Diet, Nutrition, Physical Activity and Breast Cancer. 2017. wcrf.org/breast-cancer-2017. All CUP reports are available at wcrf.org/cupreports.
8.
Michels KB, Terry KL, Willett WC: Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006;166:2395-2402.
9.
Dowsett M, Folkerd E: Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 2015;149:1-4.
10.
Pierobon M, Frankenfeld CL: Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;137:307-314.
11.
Li C (ed): Breast Cancer Epidemiology. New York, Springer, 2010.
12.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
13.
Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L: Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 2003;106:96-102.
14.
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE: Adult weight change and risk of postmenopausal breast cancer. JAMA 2006;296:193-201.
15.
Chlebowski RT LJ, Anderson GL, Simon M, et al: Weight change in postmenopausal women and breast cancer risk in the Women's Health Initiative Observational Study. GS5-07, San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 5-9, 2017.
16.
Strand F, Humphreys K, Holm J, et al: Large breast cancers in women attending regular screening: risk factors and implications for prognosis. Ann Meet Radiol Soc N Am; Nov 26-Dec 1, 2017, Chicago, IL.
17.
Wang F, Liu L, Cui S, et al: Distinct effects of body mass index and waist/hip ratio on risk of breast cancer by joint estrogen and progestogen receptor status: results from a case-control study in Northern and Eastern China and implications for chemoprevention. Oncologist 2017;22:1431-1443.
18.
Bjorner S, Rosendahl AH, Simonsson M, et al: Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer. Front Endocrinol (Lausanne) 2017;8:332.
19.
Gunter MJ, Hoover DR, Yu H, et al: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
20.
Kaaks R, Johnson T, Tikk K, et al: Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status - a prospective study within the EPIC cohort. Int J Cancer 2014;134:2683-2690.
21.
Neilson HK, Farris MS, Stone CR, Vaska MM, Brenner DR, Friedenreich CM: Moderate-vigorous recreational physical activity and breast cancer risk, stratified by menopause status: a systematic review and meta-analysis. Menopause 2017;24:322-344.
22.
Friedenreich CM: Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 2011;188:125-139.
23.
Friedenreich CM, Cust AE: Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008;42:636-647.
24.
Lope V, Martin M, Castello A, et al: Physical activity and breast cancer risk by pathological subtype. Gynecol Oncol 2017;144:577-585.
25.
Boeke CE, Eliassen AH, Oh H, Spiegelman D, Willett WC, Tamimi RM: Adolescent physical activity in relation to breast cancer risk. Breast Cancer Res Treat 2014;145:715-724.
26.
Dallal CM, Brinton LA, Matthews CE, et al: Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk. Breast Cancer Res Treat 2012;134:1279-1290.
27.
Johnsson A, Broberg P, Johnsson A, Tornberg AB, Olsson H: Occupational sedentariness and breast cancer risk. Acta Oncol 2017;56:75-80.
28.
Nomura SJ, Dash C, Rosenberg L, Palmer J, Adams-Campbell LL: Sedentary time and breast cancer incidence in African American women. Cancer Causes Control 2016;27:1239-1252.
29.
Scoccianti C, Lauby-Secretan B, Bello PY, Chajes V, Romieu I: Female breast cancer and alcohol consumption: a review of the literature. Am J Prev Med 2014;46(3 suppl 1):S16-25.
30.
Harris HR, Willett WC, Vaidya RL, Michels KB: An adolescent and early adulthood dietary pattern associated with inflammation and the incidence of breast cancer. Cancer Res 2017;77:1179-1187.
31.
Toledo E, Salas-Salvado J, Donat-Vargas C, et al: Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med 2015;175:1752-1760.
32.
Terry PD, Miller AB, Rohan TE: Cigarette smoking and breast cancer risk: a long latency period? Int J Cancer 2002;100:723-728.
33.
Dossus L, Boutron-Ruault MC, Kaaks R, et al: Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer 2014;134:1871-1888.
34.
Glantz SA, Johnson KC: The surgeon general report on smoking and health 50 years later: breast cancer and the cost of increasing caution. Cancer Epidemiol Biomarkers Prev 2014;23:37-46.
35.
McKenzie F, Ferrari P, Freisling H, et al: Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study. Int J Cancer 2015;136:2640-2648.
36.
Ellingjord-Dale M, Vos L, Hjerkind KV, et al: Alcohol, physical activity, smoking, and breast cancer subtypes in a large, nested case-control study from the Norwegian Breast Cancer Screening Program. Cancer Epidemiol Biomarkers Prev 2017;26:1736-1744.
37.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017;317:2402-2416.
38.
Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2013. Bethesda, National Cancer Institute, 2016.
39.
Liede A, Mansfield CA, Metcalfe KA, et al: Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Res Treat 2017;165:433-444.
40.
Lubinski J, Huzarski T, Byrski T, et al: The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer 2012;131:229-234.
41.
Narod SA: BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 2010;7:702-707.
42.
Friebel TM, Domchek SM, Rebbeck TR: Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju091.
43.
Pettapiece-Phillips R, Narod SA, Kotsopoulos J: The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers. Cancer Causes Control 2015;26:333-344.
44.
King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-646.
45.
Kotsopoulos J, Olopado OI, Ghadirian P, et al: Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005;7:R833-843.
46.
Pijpe A, Manders P, Brohet RM, et al: Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2010;120:235-244.
47.
Neilson HK, Conroy SM, Friedenreich CM: The influence of energetic factors on biomarkers of postmenopausal breast cancer risk. Curr Nutr Rep 2014;3:22-34.
48.
Wang M, Yu B, Westerlind K, et al: Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland. Breast Cancer Res Treat 2009;115:213-220.
49.
Grill S, Yahiaoui-Doktor M, Dukatz R, et al: Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis. Arch Gynecol Obstet 2017;296:1135-1144.
50.
Pettapiece-Phillips R, Kotlyar M, Chehade R, et al: Uninterrupted sedentary behavior downregulates BRCA1 gene expression. Cancer Prev Res (Phila) 2016;9:83-88.
51.
Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P: Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 2006;98:285-294.
52.
Nkondjock A, Ghadirian P: Diet quality and BRCA-associated breast cancer risk. Breast Cancer Res Treat 2007;103:361-369.
53.
Tryggvadottir L, Sigvaldason H, Olafsdottir GH, et al: Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 2006;98:116-122.
54.
Quante AS, Herz J, Whittemore AS, Fischer C, Strauch K, Terry MB: Assessing absolute changes in breast cancer risk due to modifiable risk factors. Breast Cancer Res Treat 2015;152:193-197.
55.
Digianni LM, Rue M, Emmons K, Garber JE: Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations. Cancer Epidemiol Biomarkers Prev 2006;15:70-75.
56.
Spector D: Lifestyle behaviors in women with a BRCA1 or BRCA2 genetic mutation: an exploratory study guided by concepts derived from the Health Belief Model. Cancer Nurs 2007;30:E1-10.
57.
Kim SJ, Zuchniak A, Sohn KJ, et al: Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study. Am J Clin Nutr 2016;104:671-677.
58.
Wright CE, Harvie M, Howell A, Evans DG, Hulbert-Williams N, Donnelly LS: Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention. Hered Cancer Clin Pract 2015;13:1.
59.
Kiechle M, Engel C, Berling A, et al: Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial. Trials 2016;17:368.
60.
Kiechle M, Dukatz R, Yahiaoui-Doktor M, et al: Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1). BMC Cancer 2017;17:752.
© 2018 S. Karger GmbH, Freiburg
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
